What are the key differences between WIPO ST.25 and the new sequence rules for applications filed after July 1, 2022?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The MPEP 2420 indicates a significant change in the rules governing…

Read More

When do the Sequence Rules apply to patent applications?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The Sequence Rules apply to patent applications containing nucleotide sequence and/or…

Read More

What are the requirements for international applications disclosing nucleic acid or amino acid sequences?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. For international applications subject to WIPO ST.25 requirements that disclose nucleic…

Read More

How does WIPO Standard ST.26 differ from WIPO Standard ST.25 for sequence listings?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. WIPO Standard ST.26 and ST.25 are different standards for sequence listings in patent applications:…

Read More